FIBK:NASDAQFirst Interstate BancSystem, Inc. Analysis
Data as of 2026-04-03 - not real-time
$33.48
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
First Interstate BancSystem (FIBK) trades around $33.48, well below its DCF‑derived fair value of roughly $73, indicating a substantial undervaluation. The stock benefits from a low price‑to‑earnings multiple of ~11.4 versus the industry average of 16.6, a sub‑1.0 price‑to‑book ratio, and an attractive dividend yield of 5.6% supported by a 63.9% payout ratio. Recent earnings have shown a robust 34% revenue growth year‑over‑year, and operating margins remain healthy at about 47%, while the MACD histogram turned positive and volume is on the rise, suggesting short‑term bullish momentum.
However, the 30‑day volatility of nearly 30% and a beta around 1.0 point to market sensitivity, and regulatory headwinds typical for regional banks add a layer of risk. Despite these factors, the combination of strong cash flow, sustainable dividend policy, and significant upside potential (median analyst target ~12% above current price) makes FIBK a compelling candidate for investors seeking both income and capital appreciation.
However, the 30‑day volatility of nearly 30% and a beta around 1.0 point to market sensitivity, and regulatory headwinds typical for regional banks add a layer of risk. Despite these factors, the combination of strong cash flow, sustainable dividend policy, and significant upside potential (median analyst target ~12% above current price) makes FIBK a compelling candidate for investors seeking both income and capital appreciation.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Positive MACD histogram and increasing volume
- Current price near technical support with upside to resistance
- High dividend yield offering immediate income
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth of 34% YoY
- Valuation gap: market price vs DCF fair value
- Sustainable dividend backed by solid cash flow
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistently low P/E and P/B relative to peers
- Robust operating margins and stable earnings
- Long‑term income potential from a 5.6% dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth34.40%
Profit Margin29.27%
P/E Ratio11.4
ROE8.95%
ROA1.08%
P/B Ratio1.0
Op. Cash Flow$305.6M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI45.4
Support$31.62
Resistance$34.80
MA 20$33.25
MA 50$35.40
MA 200$32.91
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair Value$73.11
Target Price$38.63
Upside/Downside15.37%
GradeUndervalued
TypeBlend
Dividend Yield5.60%
Risk Assessment
Beta1.01
Volatility29.78%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.